Dale E. Sharp

1.0k citations
13 papers · 878 indexed · 1 hit paper · h-index 12

Dale E. Sharp

13 papers receiving 850 citations

Hit Papers

Empagliflozin, a novel selective sodium glucose cotranspo...4942011202620162021100200300400

Peers

Dale E. Sharp
Comparison fields: 5 of 78
  • Endocrinology, Diabetes and Metabolism 481
  • Surgery 324
  • Neurology 88
  • Nephrology 40
  • Molecular Biology 361
Replace Ziro Suzuoki with:
Ziro Suzuoki Japan
Christopher Ho United States
Yusuke Moritoh Japan
Joelle M. Onorato United States
Jacek Kasznicki Poland
Ryan A. Frieler United States
Korekiyo Wakitani Japan
Yoshimi Imura Japan
Amit Joharapurkar India
C. Cojocel Germany
Dale E. Sharp relative to Ziro Suzuoki Japan Ziro Suzuoki's profile →
Citations per field
00.5×
Ziro Suzuoki · 1×
Citations per year

Countries citing papers authored by Dale E. Sharp

Since Specialization
Citations

This map shows the geographic impact of Dale E. Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale E. Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale E. Sharp more than expected).

Fields of papers citing papers by Dale E. Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale E. Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale E. Sharp. The network helps show where Dale E. Sharp may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dale E. Sharp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dale E. Sharp Line = papers co-authored together Dale E. Sharp links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 201424
2 201426
3
Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitorsbreakdown →
2011494
4 199839
5 199634
6 199018
7 1988110
8 198722
9 198629
10 198445
11 198018
12 198018
13 19801

About Dale E. Sharp

Dale E. Sharp is a scholar working on Biochemistry, Complementary and alternative medicine, Spectroscopy, Endocrinology, Diabetes and Metabolism and Organic Chemistry, having authored 13 papers that have together received 878 indexed citations. Recurring topics across this work include Analytical Chemistry and Chromatography (3 papers), Diabetes Treatment and Management (3 papers), Plant chemical constituents analysis (2 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (2 papers), Traditional Chinese Medicine Analysis (2 papers), Pancreatic function and diabetes (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (481 citations), Surgery (324 citations), Neurology (88 citations), Nephrology (40 citations) and Molecular Biology (361 citations). Dale E. Sharp has collaborated with scholars based in United States and Germany. Frequent co-authors include Peter Eickelmann, Rolf Grempler, Thomas Klein, Michael Mark, Frank Himmelsbach, Achim Sauer, Leo Thomas, Matthias Eckhardt, Remko A. Bakker and Zvani L. Rossetti. Their work appears in journals such as Diabetes Obesity and Metabolism, Transfusion, Toxicological Sciences, Journal of Pharmacology and Experimental Therapeutics and Xenobiotica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026